Jubilant Pharmova Ltd Share Price – NSE /  BSE

Pharmaceuticals, Small Cap

Jubilant Pharmova announced that the Board of Directors of the Company at its meeting held on 22 May 2026, inter alia, have recommended the final dividend of Rs 5 per equity Share (i.e. 500%) , subject to the approval of the shareholders.

Net profit of Jubilant Pharmova declined 22.27% to Rs 119.40 crore in the quarter ended March 2026 as against Rs 153.60 crore during the previous quarter ended March 2025. Sales rose 18.60% to Rs 2272.20 crore in the quarter ended March 2026 as against Rs 1915.80 crore during the previous quarter ended March 2025.

For the full year,net profit declined 52.53% to Rs 398.50 crore in the year ended March 2026 as against Rs 839.40 crore during the previous year ended March 2025. Sales rose 14.36% to Rs 8225.00 crore in the year ended March 2026 as against Rs 7192.10 crore during the previous year ended March 2025.

Powered by Capital Market - Live News

Jubilant Pharmova has fixed 24 July 2026 as record date for purpose of final dividend payment of Rs 5 per equity share of Re 1 for FY 2026.

Jubilant Pharmova will hold a meeting of the Board of Directors of the Company on 22 May 2026.